{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-23-000040","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.441507+00:00","generated_at":"2026-06-12T22:29:20.040650+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tenet Q2 net income $123M ($1.15/diluted); raises FY23 EBITDA view to $3.31-3.46B","bullets":["Net income from continuing ops $123M ($1.15/diluted); adjusted EPS $1.44; revenue $5.08B, up from $4.64B YoY.","Ambulatory Care Adj. EBITDA ex-grant $369M (+16.4% YoY); same-facility surgical cases +6.6%.","Hospital segment Adj. EBITDA ex-grant $381M; same-hospital admissions +3.0%, non-COVID admissions +5%.","FY2023 Adj. EBITDA guidance raised to $3.31-3.46B; FCF outlook $1.1-1.35B.","Completed $1.35B 6.75% notes private placement; redeemed $1.345B 4.625% notes due 2024; no debt maturities until 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-23-000040","json":"https://secwatch.observer/filing/0000070318-23-000040.json","markdown":"https://secwatch.observer/filing/0000070318-23-000040.md","text":"https://secwatch.observer/filing/0000070318-23-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000040/0000070318-23-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000040/thc-20230731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T22:29:20.040650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8c9ae736307ff3eaa4ff11ffab5f7fd6b624b914","claim":"TENET HEALTHCARE CORP reported the quarter ended June 30, 2023 results: revenue $5,082, net income $123, EPS $1.15. Guidance raised.","evidence_excerpt":"Three Months Ended June 30, Six Months Ended June 30, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,082 $4,638 $10,103 $9,383 Net income available to Tenet common shareholders from continuing operations $123 $38 $266 $177 Net income available to Tenet common shareholders from continuing operations per diluted share $1.15 $0.35 $2.47 $1.63 Adjusted EBITDA 1 excluding grant income $835 $749 $1,664 $1,631 Adjusted EBITDA 1 $843 $843 $1,675 $1,731 Adjusted diluted earnings per share from continuing operations 1 $1.44 $1.48 $2.87 $3.33","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000040/0000070318-23-000040-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$5,082"},{"label":"Net income","value":"$123"},{"label":"EPS","value":"$1.15"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}